Delivery Order SPE2DB25D7067-SPE2DB26FSUFC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Fosfomycin 3 GM sachets with a ceiling value of $1,056.00. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion on November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,128.26 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of August 7, 2025, just one day after the award date of August 6, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,706.63 by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Fosfomycin 3 GM sachets, an antibiotic pharmaceutical product. The contract is firm fixed price with a completion date of September 16, 2025, and represents a non-competitive set-aside award. Performance of this delivery order will take place at the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.72 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets. This competitively awarded, firm fixed-price contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.50 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic pharmaceutical product. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and utilized firm fixed pricing under a non-set-aside, competitive procurement process. Performance of this delivery order is based in Conshohocken, Pennsylvania, the headquarters location of AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $3,798.03 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. This competitive, non-set-aside contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes a firm fixed price structure, reflecting a straightforward pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,643.52 to AmerisourceBergen Drug Corp for the supply of Fosfomycin 3 GM sachets, an antibiotic medication. This competitive award, issued on September 16, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This is a delivery order (SPE2DB22D3016|SPE2DB24FBFK9) awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp for the supply of 4,565,618,229 units of Fosfomycin 3 GM sachets. The contract has a ceiling value of $1,120.23 and is a firm fixed price contract. The period of performance extends through August 29, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,146.64, is for the delivery of 4,567,909,932 units of Fosfomycin 3 GM Sachets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 15, 2025. The contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,287.23 firm fixed price delivery order is for the provision of 4,564,085,519 units of the antibiotic medication Fosfomycin 3 GM Sachets. The award is associated with a larger indefinite delivery contract (IDC)...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB26FSUFCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Fosfomycin 3 GM sachets, an antibiotic pharmaceutical product. This non-set-aside, competitively awarded contract is valued at $1,154.12 with a firm fixed price structure and an ultimate completion date of October 31, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products, medical supplies, generic and brand-name drugs, vaccines, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. The company's contract portfolio demonstrates extensive experience fulfilling federal medical supply requirements through competitive procurement, with delivery orders ranging substantially in value and covering diverse pharmaceutical categories to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/30/25 |